Citigroup’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$8 6021
2025
Q4
$8 Sell
1
-15
-94% -$121 ﹤0.01% 5823
2025
Q3
$129 Sell
16
-945
-98% -$8.11K ﹤0.01% 5793
2025
Q2
$6.04K Sell
961
-2,884
-75% -$24.6K ﹤0.01% 5257
2025
Q1
$35.2K Sell
3,845
-479
-11% -$1.82K ﹤0.01% 4972
2024
Q4
$10.1K Buy
4,324
+428
+11% +$4.16K ﹤0.01% 5379
2024
Q3
$56.9K Buy
3,896
+2,721
+232% +$42.2K ﹤0.01% 4981
2024
Q2
$20.1K Buy
+1,175
New +$25.7K ﹤0.01% 4997
2023
Q4
Sell
-1
Closed -$5 5729
2023
Q3
$5 Buy
+1
New +$5 ﹤0.01% 5626
2021
Q2
Sell
-44
Closed -$3K 6165
2021
Q1
$3K Buy
+44
New +$3.69K ﹤0.01% 5994
2019
Q1
Sell
-7
Closed -$1K 7669
2018
Q4
$1K Buy
+7
New +$2.39K ﹤0.01% 7559

Other funds holding CRVO